USPTO 2015–2025 USPTO PatentsView US Corporation

Merrimack Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 34 granted patents across 12 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Merrimack ranks #9,320 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 12 technology areas.

#9,320
of 49,997 US assignees by volume
Top 49%
by Innovation Score (35.5/100)
18.2
avg claims per patent
-97%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9320 · US Corporation #9,320 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 34 grants
  • UPPER-Q #9,320/49,997
  • PHOTO-FINISH Mainetti (UK)
  • CPC-FOCUS A61K · 12 areas
  • INNOV-THIN 35.5/100
  • CLAIMS-RICH 18.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -97% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mainetti (UK) Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Merrimack’s 35.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Merrimack

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Merrimack's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Merrimack?

Each dot is one of Merrimack’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Merrimack’s own 18.2 claims/patent is ABOVE the 10.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Merrimack vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 33.934.034.03434.034.034.1 05101520 Granted patents (volume) Avg claims / patent Mainetti (UK) Ltd - 34, 1.38Mainetti (UK)Maquet Cardiopulmonary GmbH - 34, 8.06Maquet Cardiopulm…Medtronic Ventor Technologies Ltd. - 34, 18.26Medtronic VentorMercury Plastics LLC - 34, 15.47Mercury PlasticsMesser Industries USA, Inc. - 34, 11.79Messer Industries…National University Corporation, Iwate University - 34, 10.44National Universi…Neofect Co., Ltd. - 34, 7.32NeofectNextremity Solutions, Inc. - 34, 14.68Nextremity Soluti…Merrimack Pharmaceuticals, Inc. - 34, 18.21Merrimack Pharmac…
Merrimack vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Merrimack's grants concentrate

Merrimack Pharmaceuticals, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (13 grants) versus a trough of 1 in 2020. By volume, Merrimack sits between Mainetti (UK) Ltd and Nextremity Solutions, Inc..

Who files at Merrimack's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Merrimack holds 34 patents at rank #9,326, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Merrimack

By rank, the assignees closest to #9,326 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Merrimack's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Merrimack, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Merrimack ranks #650 of 7,163 assignees by patent count in that subclass.

Merrimack's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 49% higher than 51% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 201520162017201820192020 1
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Merrimack Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 11.8%
2016 13 38.2%
2017 5 14.7%
2018 9 26.5%
2019 2 5.9%
2020 1 2.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Merrimack Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

  • Merrimack Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #9,320 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Merrimack Pharmaceuticals, Inc. against Mainetti (UK) Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.